Time to Reach Glycaemic and Body Weight Loss Thresholds with Tirzepatide in Patients with Type 2 Diabetes: A Pre-planned Exploratory Analysis of SURPASS-2 and SURPASS-3

Overview of attention for article published in Diabetes Therapy, March 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 2,033 followers.

RT @RodolfoJGalindo: #Tirzepatide vs. #degludec or #Semaglutide 1mg: faster and higher % of pp #T2d achieved #hba1c and weight loss goals.…

#Tirzepatide vs. #degludec or #Semaglutide 1mg: faster and higher % of pp #T2d achieved #hba1c and weight loss goals. No fear that titration is low = potency wins!!! https://t.co/Ou5MWJFZh8 https://t.co/fw53hTPrsz

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.